Grape King Bio Ltd (1707) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.032x

Based on the latest financial reports, Grape King Bio Ltd (1707) has a cash flow conversion efficiency ratio of 0.032x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$380.02 Million ≈ $11.97 Million USD) by net assets (NT$11.83 Billion ≈ $372.64 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Grape King Bio Ltd (1707) market capitalisation for the company's overall valuation and market capitalisation.

Grape King Bio Ltd - Cash Flow Conversion Efficiency Trend (2002–2025)

This chart illustrates how Grape King Bio Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Grape King Bio Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Grape King Bio Ltd ranked by their cash flow conversion efficiency. Explore Grape King Bio Ltd (1707) cash earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
Hengyuan Refining Company Bhd KLSE:4324	0.281x
Singaraja Putra JK:SINI	0.040x
Norske Skog Asa OL:NSKOG	-0.052x
Beijing Haohan Data Technology Co. Ltd. A SHG:688292	N/A
Lion Travel Service Co Ltd TW:2731	0.143x
Shenzhen Prolto Supply Chain Management Co Ltd SHE:002769	0.059x
PRA Group Inc NASDAQ:PRAA	-0.010x
Einhell Germany AG F:EIN	0.049x

Annual Cash Flow Conversion Efficiency for Grape King Bio Ltd (2002–2025)

The table below shows the annual cash flow conversion efficiency of Grape King Bio Ltd from 2002 to 2025. View today's stock price for Grape King Bio Ltd for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$12.07 Billion ≈ $380.16 Million	NT$2.18 Billion ≈ $68.68 Million	0.181x	+13.55%
2024-12-31	NT$11.79 Billion ≈ $371.47 Million	NT$1.88 Billion ≈ $59.10 Million	0.159x	-26.56%
2023-12-31	NT$11.63 Billion ≈ $366.41 Million	NT$2.52 Billion ≈ $79.37 Million	0.217x	-19.29%
2022-12-31	NT$11.14 Billion ≈ $351.00 Million	NT$2.99 Billion ≈ $94.22 Million	0.268x	+10.12%
2021-12-31	NT$10.43 Billion ≈ $328.58 Million	NT$2.54 Billion ≈ $80.09 Million	0.244x	-28.48%
2020-12-31	NT$7.98 Billion ≈ $251.37 Million	NT$2.72 Billion ≈ $85.67 Million	0.341x	+17.26%
2019-12-31	NT$7.47 Billion ≈ $235.37 Million	NT$2.17 Billion ≈ $68.41 Million	0.291x	-16.64%
2018-12-31	NT$6.93 Billion ≈ $218.44 Million	NT$2.42 Billion ≈ $76.16 Million	0.349x	-11.59%
2017-12-31	NT$6.33 Billion ≈ $199.37 Million	NT$2.50 Billion ≈ $78.63 Million	0.394x	-18.64%
2016-12-31	NT$5.78 Billion ≈ $182.19 Million	NT$2.80 Billion ≈ $88.31 Million	0.485x	+56.50%
2015-12-31	NT$4.22 Billion ≈ $132.94 Million	NT$1.31 Billion ≈ $41.18 Million	0.310x	-32.34%
2014-12-31	NT$3.72 Billion ≈ $117.10 Million	NT$1.70 Billion ≈ $53.60 Million	0.458x	-6.43%
2013-12-31	NT$3.22 Billion ≈ $101.47 Million	NT$1.58 Billion ≈ $49.65 Million	0.489x	+19.64%
2012-12-31	NT$2.74 Billion ≈ $86.39 Million	NT$1.12 Billion ≈ $35.33 Million	0.409x	+19.10%
2011-12-31	NT$2.47 Billion ≈ $77.86 Million	NT$848.53 Million ≈ $26.73 Million	0.343x	+13.46%
2010-12-31	NT$2.26 Billion ≈ $71.20 Million	NT$683.89 Million ≈ $21.55 Million	0.303x	-12.82%
2009-12-31	NT$2.08 Billion ≈ $65.40 Million	NT$720.61 Million ≈ $22.70 Million	0.347x	+39.24%
2008-12-31	NT$1.74 Billion ≈ $54.95 Million	NT$434.85 Million ≈ $13.70 Million	0.249x	+74.65%
2007-12-31	NT$1.77 Billion ≈ $55.86 Million	NT$253.11 Million ≈ $7.97 Million	0.143x	-48.28%
2006-12-31	NT$1.70 Billion ≈ $53.52 Million	NT$468.84 Million ≈ $14.77 Million	0.276x	+26.09%
2005-12-31	NT$1.60 Billion ≈ $50.42 Million	NT$350.26 Million ≈ $11.04 Million	0.219x	+597.83%
2004-12-31	NT$1.58 Billion ≈ $49.75 Million	NT$49.53 Million ≈ $1.56 Million	0.031x	-65.88%
2003-12-31	NT$1.48 Billion ≈ $46.75 Million	NT$136.42 Million ≈ $4.30 Million	0.092x	+75.77%
2002-12-31	NT$1.46 Billion ≈ $46.03 Million	NT$76.42 Million ≈ $2.41 Million	0.052x	--

About Grape King Bio Ltd

TW:1707 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$424.71 Million

NT$13.48 Billion TWD

Market Cap Rank

#13279 Global

#508 in Taiwan

Share Price

NT$91.00

Change (1 day)

+0.55%

52-Week Range

NT$88.40 - NT$131.50

All Time High

NT$227.99